@FierceMedDev: Veracyte, a molecular diagnostic company, has filed plans for an IPO. Story | Follow @FierceMedDev
@DamianFierce: FDA device chief Jeffrey Shuren blogs about "landmark" UDI rule. More | Follow @DamianFierce
@MarkHFierce: RainDance, a maker of gene-sequencing tools, raised up to $35M in debt financing to keep the sales push going. Article | Follow @MarkHFierce
@MichaelGFierce: ICYMI: Bind collects $70.5M IPO to support Accurin tech. More from FierceDrugDelivery | Follow @MichaelGFierce
> U.K. researchers have developed a metal stent made of nitinol designed to tackle treatment-resistant high blood pressure. It behaves like a paper clip, joining an artery and vein together in the groin. Story
> Israel's LabStyle Innovations gained a CE mark for Dario, its smartphone-based glucose monitor for diabetes patients. Item
> Illumina ($ILMN) has appointed Gates Foundation veteran Richard Klausner to serve as chief medical officer. News
> Test maker Alere ($ALR) has partnered with Malaria No More to launch a fundraising campaign to combat the disease in Africa. More
> When the European Commission votes on proposed new medical device regulations, it will have to consider a whole new set of amendments. Story
> B. Braun won FDA approval for a new line of large-volume intravenous bags. Release
Biotech News
@FierceBiotech: ICYMI Friday: San Diego biotech insider accused of shooting RNAi expert and brother-in-law. Article | Follow @FierceBiotech
@JohnCFierce: Perlmutter has been working hard to create a new narrative for Merck R&D. More efficient, smarter, focused on winners. Legacy bites again. | Follow @JohnCFierce
@EmilyMFierce: NIH launches $45M Alzheimer's research effort, awards funds to 3 preclinical studies. Story from FierceBiotech Research | Follow @EmilyMFierce
> Merck R&D hammered by another setback as FDA rejects anesthesia drug (again). Story
> Roche lung cancer drug bags another 'breakthrough' at the FDA. News
> Ablynx lands $840M AbbVie deal on next-gen Humira successor. Article
Pharma News
@FiercePharma: Big Pharma pressures U.K. officials on cancer drug use as special fund set to expire. More from PMLiVE | Follow @FiercePharma
@EricPFierce: COPD market is growing rapidly but so is the number of drugs approved to treat it. Novartis gets in. Story | Follow @EricPFierce
> Who are the richest biopharma execs? Not all the usual suspects. Report
> Novartis board to shrink executive pay, director says. More
CRO News
> Quintiles seals deal for Novella. News
> PPD lures UCB exec to head immunology. Report
> Capsugel expands in U.S., Europe. Item
> CMO Aesica puts up $48M to make diabetes drugs. Article
> Catalent lands manufacturing deal with Supernus. More
> InVentiv partners up for policy, site selection. Story
Biotech IT News
> BRAIN Initiative prioritizes better data storage and analysis. More
> Biotech broker fined $5,000 for venting on Facebook. Item
> FDA posts final guidance on electronic source data. Story
> Google hires ex-Genentech CEO to lead ambitious bio spinoff. Report
> Bioinformatics-driven Eisai subsidiary inks discovery alliance. News
> New York Genome Center opens $54M biomedical-research hub. Article